Core Scientific price target lowered to $17 from $20 at Roth Capital

Roth Capital analyst Darren Aftahi lowered the firm’s price target on Core Scientific (CORZ) to $17 from $20 and keeps a Neutral rating on the shares. The company’s deal with CoreWeave (CRWV) will ultimately get done, but at revised economics, the analyst tells investors in a research note. Roth adds that it sees “better risk/reward” elsewhere in its digital infrastructure coverage space.

Claim 55% Off TipRanks